September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Assessment of visual morbidity amongst diabetic retinopathy at tertiary eye care center, Nepal: A cross-sectional descriptive study
Author Affiliations & Notes
  • Araniko Pandey
    Ophthalmology, Lumbini Eye Institute, Bhairahawa, Nepal
  • Gyanendra Lamichhane
    Ophthalmology, Lumbini Eye Institute, Bhairahawa, Nepal
  • Roshija Khanal
    Ophthalmology, Lumbini Eye Institute, Bhairahawa, Nepal
  • Salma KC Rai
    Ophthalmology, Lumbini Eye Institute, Bhairahawa, Nepal
  • Arjun Malla Bhari
    Ophthalmology, Lumbini Eye Institute, Bhairahawa, Nepal
  • Davide Borroni
    Ophthalmology, Riga Stradins University, Riga, Latvia
  • Narayan Gautam
    Biochemistry, Universal College of Medical Sciences, Bhairahawa, Nepal
  • Footnotes
    Commercial Relationships   Araniko Pandey, None; Gyanendra Lamichhane, None; Roshija Khanal, None; Salma KC Rai, None; Arjun Malla Bhari, None; Davide Borroni, None; Narayan Gautam, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 1591. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Araniko Pandey, Gyanendra Lamichhane, Roshija Khanal, Salma KC Rai, Arjun Malla Bhari, Davide Borroni, Narayan Gautam; Assessment of visual morbidity amongst diabetic retinopathy at tertiary eye care center, Nepal: A cross-sectional descriptive study. Invest. Ophthalmol. Vis. Sci. 2016;57(12):1591.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Diabetic retinopathy (DR) is emerging globally as one of the main causes of avoidable blindness. Performing a study at a local level in a tertiary care center in Nepal, could give new insights for future perspectives on prevention and treatment of blindness caused by DR. We conducted a hospital based, cross-sectional descriptive study including 50 patients, to assess the burden of DR and awareness about visual morbidity caused by diabetes.

Methods : Non-probability, convenience sampling method was used to evaluate all consecutive cases of DR. Among them, 50 patients at any stage of DR were selected. Patients with causes other than DR for visual impairment putting diagnosis in dilemma, one eyed patients and those unwilling to participate were excluded. Best corrected visual acuity (BCVA) was recorded. Detailed slit lamp examination of anterior and posterior segment was done. DR was classified according to Early Treatment Diabetic Retinopathy Study Research Group - report no. 10 TABLE A5-1 (Modified Airlie House Classification). Data entry was done in an SPSS unit and descriptive measures were generated in tables and figures. Mean and standard deviations (SD) were computed for continuous variables and percentages for categorical ones. Wherever applicable, variables were set as 100 eyes.

Results : Commonest age group was 50-69 yrs comprising 80% of the total population (n=50) and the predominant population was males (76%). Fifty six percent (n=100) of the eyes checked had BCVA of ≤6/60, 48% had visual complaints for >1yr and only 8% had sought for eye check up with no visual complaints. Clinically significant macular edema (CSME) was prevalent in 71% of eyes (n=100). Non proliferative diabetic retinopathy (NPDR) was found in 69%, proliferative diabetic retinopathy (PDR) was found in 31% and advanced diabetic eye disease was found in 3% (n=100). All the stages of DR viz. mild NPDR, moderate NPDR, severe NPDR, early PDR and high risk PDR were seen at 15%, 27%, 27%, 10% and 18%, respectively (n=100).

Conclusions : CSME and all the stages of DR were present in significant proportions in this study. Attitude towards eye check up in diabetics seemed low. This study showed the shifting paradigm of avoidable blindness at a local level. This suggests the need for planning and implementation of strategies to prevent from blindness due to DR, in low and middle income countries.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×